Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v38-FR Version v22-EN
Language French English
Date Updated 2023-01-03 2022-03-02
Drug Identification Number 02141019 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10% CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CALCIUM GLUCONATE CALCIUM GLUCONATE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 50 mL 50 mL
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Other (Please describe in comments) Disruption of the manufacture of the drug.
Anticipated start date 2022-01-01 2022-01-01
Actual start date 2022-03-01 2022-03-01
Estimated end date 2022-12-31 2022-03-31
Actual end date 2022-12-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Effective May. 2, 2022, will be placed on allocation. Contract customers will be allocated 150% historical monthly demand. Effective Mar. 1, 2022, remaining 50mL inventory has been diverted to cover 100% of 10mL demand on a mL per mL basis for contract customers. 100% of 50mL demand to be covered by 100mL.
Health Canada comments